THE AI-BOOSTER
FOR SKIN PATHOLOGY
Innovative
transformation in skin pathology
Through the use of state-of-the-art artificial intelligence, aisencia® streamlines the workflow in skin pathology to meet the growing demand for fast, precise, and accessible diagnoses
At aisencia®, we explore and develop in ultra-close cooperation with world leading skin pathologists to meet their current and future needs
Partner / Supporters
Already analyzed samples
AI-assisted skin diagnoses
Publications
Our partners
Recent posts
Explore the recent happenings, developments, and trends in our continuous endeavor to revolutionize pathology
AI for More Precise Treatment of Head and Neck Tumors: BESTFIT Project Presented
The joint project BESTFIT was presented to the public for the first time at the kick-off meeting “AI-supported Precision Surgery in Oncology” (KIOn) organized by the German Federal Ministry of Research, Technology and Space (BMFTR) in Berlin. The aim of the collaborative project is to significantly improve therapy planning and treatment of head and neck…
aisencia® and HpH Establish New Development Partnership
On January 14, 2026, aisencia and HpH Institute of Pathology and Hematopathology Hamburg entered into a comprehensive development partnership.
Successful Implementation of our LIS at Dermatologikum Hamburg
Our team has successfully implemented Vistaneos, our innovative Laboratory Information System (LIS), at Dermatologikum Hamburg, one of Germany’s leading dermatopathology institutes.
The digital pathology workplace of the future
As part of the AI-Path project, aisencia GmbH and the Digital Media Lab at the University of Bremen are joining forces to redefine how pathologists work in the digital age.
aisencia® secures €150 000 BRE-Up funding for “DERM-BOOST”
aisencia GmbH has been awarded €150,000 in EU funding through the BRE-Up program to further develop its digital, AI-powered software solutions Vistaneos and Cutaneos 80.
aisencia® expands to Australia and welcomes new investor
We are extremely proud to welcome Pathscan Pty Ltd. from Australia as a strategic partner and investor—alongside industry leaders Dr. Ian Katz and Paul Richard.
Supported by
You want to know more information about our products?
